Your browser doesn't support javascript.
loading
Five-Year Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice.
Tural, Deniz; Arslan, Cagatay; Selcukbiricik, Fatih; Olmez, Omer Fatih; Akar, Emre; Erman, Mustafa; Ürün, Yüksel; Erdem, Dilek; Karadurmus, Nuri; Kilickap, Saadettin.
Affiliation
  • Tural D; Department of Medical Oncology, Bakirköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey. Electronic address: deniztural@gmail.com.
  • Arslan C; Department of Medical Oncology, Faculty of Medicine, Izmir University of Economics, Izmir, Turkey.
  • Selcukbiricik F; Department of Medical Oncology, Koc University Medical Faculty, Istanbul, Turkey.
  • Olmez OF; Department of Medical Oncology, Medipol University Hospital, Istanbul, Turkey.
  • Akar E; Department of Medical Oncology, Bakirköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.
  • Erman M; Department of Medical Oncology, Hacettepe University Medical Faculty, Ankara, Turkey.
  • Ürün Y; Department of Medical Oncology, Ankara University Medical Faculty, Ankara, Turkey.
  • Erdem D; Department of Medical Oncology, Medical Park Samsun Hospital, Samsun, Turkey.
  • Karadurmus N; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey.
  • Kilickap S; Department of Medical Oncology, Liv Hospital, Istinye University, Ankara, Turkey.
Clin Genitourin Cancer ; 21(3): 334-341, 2023 06.
Article in En | MEDLINE | ID: mdl-36641357

Full text: 1 Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Limits: Aged / Aged80 / Female / Humans / Male Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Limits: Aged / Aged80 / Female / Humans / Male Language: En Year: 2023 Type: Article